Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2026. Start Trial.
Date Value
October 06, 2026 6.581
October 05, 2026 6.917
October 02, 2026 6.978
October 01, 2026 7.112
September 30, 2026 7.431
September 29, 2026 7.544
September 28, 2026 7.683
September 25, 2026 7.217
September 24, 2026 7.512
September 23, 2026 7.686
September 22, 2026 8.603
September 21, 2026 8.175
September 18, 2026 8.093
September 17, 2026 8.219
September 16, 2026 8.177
September 15, 2026 8.066
September 14, 2026 7.877
September 11, 2026 7.640
September 10, 2026 7.963
September 09, 2026 8.296
September 08, 2026 8.764
September 04, 2026 8.483
September 03, 2026 8.913
September 02, 2026 9.494
September 01, 2026 8.632
Date Value
August 31, 2026 8.772
August 28, 2026 8.777
August 27, 2026 9.380
August 26, 2026 9.265
August 25, 2026 9.458
August 24, 2026 9.074
August 21, 2026 9.039
August 20, 2026 8.785
August 19, 2026 9.540
August 18, 2026 9.200
August 17, 2026 9.141
August 14, 2026 9.234
August 13, 2026 9.232
August 12, 2026 9.672
August 11, 2026 9.802
August 10, 2026 10.05
August 07, 2026 9.504
August 06, 2026 9.50
August 05, 2026 9.844
August 04, 2026 9.647
August 03, 2026 9.678
July 31, 2026 9.234
July 30, 2026 10.02
July 29, 2026 8.779
July 28, 2026 8.774

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Forte Biosciences, Inc. 8.580
AnaptysBio, Inc. 128.97
Immunovant, Inc. 8.995
ACADIA Pharmaceuticals, Inc. 2.568
Agenus, Inc. --

Price to Book Value Related Metrics

Price 30.63
Earnings Yield -16.13%
Market Cap 1.084B